期刊文献+

含CpG免疫刺激序列的质粒增强HBsAg诱导的免疫应答

Multi-copy CpG ODN-containing plasmid enhancing immune responses to HBsAg
下载PDF
导出
摘要 目的探讨以含有多拷贝CpG寡脱氧核苷酸(CpG ODN)的质粒作为治疗性乙肝疫苗佐剂的可行性。方法构建含有6个拷贝D型CpG ODN的质粒pKO-CG6,将该质粒以及载体pKO分别刺激健康人及HBV感染者的外周血单核细胞(PBMC),检测PBMC的增殖及分泌的细胞因子IFN-γ、IL-12,进一步将重组HBsAg分别联合这两种质粒免疫小鼠,检测小鼠的细胞和体液免疫应答。结果质粒pKO-CG6与载体pKO在体外均能有效激活健康人及HBV感染者PBMC增殖反应,并促进IFN-γ、IL-12的产生,其中pKO-CG6的免疫刺激活性强于载体pKO。小鼠体内试验表明,虽然载体pKO也具有免疫佐剂作用,但pKO-CG6更能显著增强HBsAg诱导的免疫应答,尤其是细胞免疫应答。结论含有多拷贝D型CpG ODN的质粒能有效激活HBV感染者的PBMC,并增强HBsAg在小鼠体内的免疫原性。 Objective To explore the possibility of using plasmid containing muti-copy of CpG ODN as the adjuvant for therapeutic vaccine against hepatitis B.Methods A plasmid pKO-CG6 containing six copies of D type CpG ODN was constructed.The plasmid and the carrier plasmid pKO were used to stimulate peripheral blood monouclear cells(PBMC) of healthy or HBV infected subjects;then the proliferation of PBMCs and secretion of IFN-γ and IL-12 were examined.Recombinant HBsAg combined with either of the plasmid was used to immunize BALB/c mice,and immune responses to HBsAg were assayed.Results Both plasmid pKO-CG6 and carrier plasmid pKO not only effectively activated the proliferation response of PBMCs from healthy controls and HBV infected subjects in vitro,but also promoted the production of IFN-γ and IL-12;the immuno-stimulation activity of pKO-CG6 was greatly stronger than that of the carrier plasmid pKO.In vivo study showed that although vector pKO could also act as immunological adjuvant for HBsAg in mice,plasmid pKO-CG6 elicited much stronger immune responses to HBsAg,especially the cell-mediated response.Conclusion Plasmid containing multi-copy of CpG ODN can effectively activate PBMCs of HBV infected subjects and enhance the immune responses to HBsAg in mice.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2012年第2期145-149,共5页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(30500452 30771929) 上海市重点建设学科基金(B901)~~
关键词 乙型肝炎病毒 CPG寡脱氧核苷酸 质粒 免疫佐剂 hepatitis B virus CpG oligodeoxynucleotides plasmids immunologic adjuvants
  • 相关文献

参考文献15

  • 1Gupta S,Sane S A,Shakya N,Vishwakarma P,Haq W.CpG oli-godeoxynucleotide 2006 and miltefosine,a potential combination fortreatment of experimental visceral leishmaniasis[J].Antimicrob A-gents Chemother,2011,55:3461-3464.
  • 2Verthelyi D,Kenney R T,Seder R A,Gam A A,Friedag B,Klin-man D M.CpG oligodeoxynucleotides as vaccine adjuvants in pri- mates[J].J Immunol,2002,168:1659-1663.
  • 3Chaput N,Schartz N E,AndréF,Taeb J,Novault S,BonnaventureP,et al.Exosomes as potent cell-free peptide-based vaccine. Ⅱ.Exosomes in CpG adjuvants efficiently prime naive Tc1 lym-phocytes leading to tumor rejection[J].J Immunol,2004,172:2137- 2146.
  • 4Liu Y,Luo X,Yang C,Yu S K,Xu H L.Three CpG oligodeoxynu-cleotide classes differentially enhance antigen-specific humoraland cellular immune responses in mice[J].Vaccine,2011,29:5778-5784.
  • 5Krug A,Rothenfusser S,Selinger S,Bock C,Kerkmann M,BattianyJ,et al.CpG-A oligonucleotides induce a monocyte- deriveddendritic cell-like phenotype that preferentially activates CD8 Tcells[J].J Immunol,2003,170:3468-3477.
  • 6Coban C,Ishii K J,Gursel M,Klinman D M,Kumar N.Effect ofplasmid backbone modification by different human CpG motifs onthe immunogenicity of DNA vaccine vectors[J].J Leukoc Biol,2005,78:647-655.
  • 7赵平,姜春鹏,赵兰娟,温新宇,戚中田.HBV包膜-核心蛋白融合基因DNA疫苗诱导小鼠持久的细胞免疫应答[J].生物化学与生物物理进展,2002,29(4):576-582. 被引量:13
  • 8Bode C,Zhao G,Steinhagen F,Kinjo T,Klinman D M.CpG DNAas a vaccine adjuvant[J].Expert Rev Vaccines,2011,10:499-511.
  • 9Tsujimoto H,Ono S,Matsumoto A,Kawabata T,Kinoshita M,Ma-jima T,et al.A critical role of CpG motifs in a murine peritonitismodel by their binding to highly expressed toll-like receptor-9on liver NKT cells[J].J Hepatol,2006,45:836-843.
  • 10Malanchere-Bres E,Payette P J,Mancini M,Tiollais P,Davis HL,Michel M L.CpG oligodeoxynucleotides with hepatitis B surfaceantigen(HBsAg)for vaccination in HBsAg-transgenic mice[J].J Virol,2001,75:6482-6491.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部